Skip to main navigation Skip to search Skip to main content

A Phase 3b, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants, Protocol V59P23

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/12/09 → 06/30/12

Funding

  • Novartis Vaccines and Diagnostics Inc: $41,154.19